NLRC5 attenuates inflammatory response in IL-1β-stimulated human osteoarthritis chondrocytes through the NF-κB signaling pathway

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• NOD-like receptor family caspase recruitment domain family domain containing 5 (NLRC5) is a key inflammatory mediator.
• The role of NLRC5 in osteoarthritis (OA) pathogenesis remains unexplored.

Purpose of the Study:

• To investigate the function of NLRC5 in chondrocytes and OA.
• To elucidate the underlying molecular mechanisms of NLRC5 in regulating inflammatory responses in OA.

Main Methods:

• Chondrocytes were treated with IL-1β to induce inflammation.
• NLRC5 expression was manipulated (overexpressed or knocked down) in chondrocytes.
• Inflammatory mediators, matrix metalloproteinases, and NF-κB signaling pathway components were analyzed.
• An OA rat model was used to assess the therapeutic potential of NLRC5.

Main Results:

• NLRC5 expression was downregulated by IL-1β induction in chondrocytes.
• NLRC5 overexpression suppressed IL-1β-induced production of inflammatory mediators (iNOS, COX-2, PGE2, NO, TNF-α, IL-6) and matrix degrading enzymes (MMP-3, MMP-13).
• NLRC5 inhibited NF-κB signaling by increasing IκBα and decreasing p-p65.
• NLRC5 treatment ameliorated cartilage degeneration in an OA rat model.

Conclusions:

• NLRC5 plays a protective role in chondrocytes against IL-1β-induced inflammation.
• NLRC5 attenuates inflammatory injury in OA by regulating the NF-κB signaling pathway.
• NLRC5 demonstrates therapeutic potential for osteoarthritis treatment.